Every investor in China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 42% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
As market cap fell to HK$14b last week, individual investors would have faced the highest losses than any other shareholder groups of the company.
Let's delve deeper into each type of owner of China Traditional Chinese Medicine Holdings, beginning with the chart below.
See our latest analysis for China Traditional Chinese Medicine Holdings
SEHK:570 Ownership Breakdown September 26th 2022
What Does The Institutional Ownership Tell Us About China Traditional Chinese Medicine Holdings?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
China Traditional Chinese Medicine Holdings already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at China Traditional Chinese Medicine Holdings' earnings history below. Of course, the future is what really matters.
SEHK:570 Earnings and Revenue Growth September 26th 2022
China Traditional Chinese Medicine Holdings is not owned by hedge funds. Our data shows that China National Service Corporation is the largest shareholder with 32% of shares outstanding. With 12% and 3.3% of the shares outstanding respectively, Ping An Insurance (Group) Company of China, Ltd. and Xiaochun Wang are the second and third largest shareholders.
On looking further, we found that 51% of the shares are owned by the top 5 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
Insider Ownership Of China Traditional Chinese Medicine Holdings
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
We can report that insiders do own shares in China Traditional Chinese Medicine Holdings Co. Limited. The insiders have a meaningful stake worth HK$469m. Most would see this as a real positive. If you would like to explore the question of insider alignment, you can click here to see if insiders have been buying or selling.
General Public Ownership
With a 42% ownership, the general public, mostly comprising of individual investors, have some degree of sway over China Traditional Chinese Medicine Holdings. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
Private Company Ownership
Our data indicates that Private Companies hold 32%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.
Public Company Ownership
It appears to us that public companies own 12% of China Traditional Chinese Medicine Holdings. We can't be certain but it is quite possible this is a strategic stake. The businesses may be similar, or work together.
Next Steps:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.
Many find it useful to take an in depth look at how a company has performed in the past. You can access this detailed graph of past earnings, revenue and cash flow.
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
每一位中國中醫藥控股有限公司(HKG:570)的投資者都應該意識到最強大的股東羣體。而持有這塊蛋糕最大份額的羣體是擁有42%股權的個人投資者。也就是説,如果股價上漲,該集團將受益最大(如果股價下跌,該集團將損失最大)。
隨着上週市值跌至140億港元,個人投資者將面臨比該公司任何其他股東羣體都要高的損失。
讓我們從下面的圖表開始,更深入地調查中國中醫藥控股公司的每種類型的所有者。
查看我們對中國中醫藥控股公司的最新分析
聯交所:570擁有權分類2022年9月26日
機構所有權告訴了我們關於中國中醫藥控股公司的什麼?
機構通常在向自己的投資者報告時,以基準來衡量自己,因此一旦一隻股票被納入主要指數,它們往往會對這隻股票變得更加熱情。我們預計,大多數公司都會有一些機構登記在冊,特別是在它們正在增長的情況下。
中國中醫藥控股股份有限公司已經在股票登記處登記了機構。事實上,他們在該公司擁有可觀的股份。這表明在專業投資者中有一定的可信度。但我們不能僅僅依靠這一事實,因為機構有時會做出糟糕的投資,就像每個人一樣。如果多家機構同時改變對一隻股票的看法,你可能會看到股價迅速下跌。因此,下面的中國中醫藥控股公司的盈利歷史值得一看。當然,未來才是真正重要的。
聯交所:570盈利及收入增長2022年9月26日
中國中醫藥控股有限公司並非由對衝基金所有。我們的數據顯示,中國服務總公司是第一大股東,持有32%的流通股。中國中國平安(集團)股份有限公司和王曉春分別以12%和3.3%的流通股比例位居第二和第三大股東。
進一步觀察,我們發現前五大股東持有51%的股份。換句話説,這些股東在公司的決策中擁有有意義的發言權。
雖然研究一家公司的機構所有權數據是有意義的,但研究分析師的情緒以瞭解風向也是有意義的。有相當數量的分析師追蹤該股,因此瞭解他們對未來的總體看法可能是有用的。
中國中醫藥控股公司的內部人所有權
不同國家對內部人的定義可能略有不同,但董事會成員總是算數的。公司管理層對董事會負責,董事會應代表股東的利益。值得注意的是,有時最高層管理人員本身也是董事會成員。
我通常認為內部人持股是一件好事。然而,在某些情況下,這會讓其他股東更難讓董事會對決策負責。
我們可以報告,內部人士確實持有中國中醫藥控股有限公司的股份。這些內部人士持有價值4.69億港元的可觀股份。大多數人會認為這是一個真正的積極因素。如果你想探討內部人結盟的問題,你可以點擊這裏,看看內部人是一直在買入還是賣出。
一般公有制
持有42%股權的普通公眾,主要由個人投資者組成,對中國中醫藥控股公司有一定程度的影響力。雖然這羣人不一定能發號施令,但它肯定能對公司的運營方式產生真正的影響。
私營公司所有權
我們的數據顯示,私營公司持有該公司32%的股份。私營公司可能是關聯方。有時,內部人士通過持有一傢俬人公司來對上市公司感興趣,而不是以個人身份。雖然很難得出任何大致的中風結論,但值得注意的是,這是一個值得進一步研究的領域。
上市公司所有權
在我們看來,上市公司擁有中國中醫藥控股公司12%的股份。我們不能確定,但很有可能這是一個戰略利益攸關方。這些業務可能是相似的,也可能是合作的。
接下來的步驟:
我發現看看到底是誰擁有一家公司是非常有趣的。但為了真正獲得洞察力,我們還需要考慮其他信息。
許多人認為它很有用要深入瞭解一家公司過去的表現。您可以訪問此詳細圖表過去的收益、收入和現金流。
如果你像我一樣,你可能會想一想這家公司是會增長還是會萎縮。幸運的是,您可以查看這份顯示分析師對其未來預測的免費報告。
注:本文中的數字是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間。這可能與全年的年度報告數字不一致。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。